Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
3.
Rev Med Suisse ; 5(224): 2229-30, 2232-4, 2009 Nov 04.
Artículo en Francés | MEDLINE | ID: mdl-19994672

RESUMEN

Iron deficiency (ID) without anaemia frequently remains undiagnosed when symptoms are attributed to ID with anaemia. Serum ferritin is the primary diagnostic parameter, whereas <10 microg/l represent depleted iron stores, 10-30 microg/l can confirm ID without anaemia and 30-50 microg/l might indicate functional ID. In case of increased CRP or ALT, normal/elevated ferritin should be interpreted with caution. IV iron is indicated if oral iron is not effective or tolerated. At ferritin <10 microg/l, a cumulative dose of 1000 mg iron and at ferritin 10-30 microg/l, a cumulative dose of 500 mg is advised. At ferritin 30-50 microg/l a first dose of 200 mg might be considered. Ferritin shall be reassessed not sooner than 2 weeks after the last oral or 8-12 weeks after the last IV iron administration.


Asunto(s)
Deficiencias de Hierro , Enfermedades Carenciales/diagnóstico , Enfermedades Carenciales/tratamiento farmacológico , Humanos
4.
Praxis (Bern 1994) ; 98(24): 1445-51, 2009 Dec 02.
Artículo en Alemán | MEDLINE | ID: mdl-19953470

RESUMEN

Iron deficiency (ID) without anaemia frequently remains undiagnosed when symptoms are attributed to ID with anaemia. Serum ferritin is the primary diagnostic parameter, whereas <10 microg/l represent depleted iron stores, 10-30 microg/l can confirm ID without anaemia and 30-50 microg/l might indicate functional ID. In case of increased CRP or ALT, normal/elevated ferritin should be interpreted with caution. Intravenous iron is indicated if oral iron is not effective or tolerated. At ferritin <10 microg/l, a cumulative dose of 1000 mg iron and at ferritin 10-30 microg/l, a cumulative dose of 500 mg is advised. At ferritin 30-50 microg/l a first dose of 200 mg might be considered. Ferritin shall be reassessed not sooner than 2 weeks after the last oral or 8-12 weeks after the last iv iron administration.


Asunto(s)
Anemia Ferropénica/diagnóstico , Deficiencias de Hierro , Alopecia/sangre , Alopecia/etiología , Anemia Ferropénica/sangre , Trastornos del Conocimiento/sangre , Trastornos del Conocimiento/etiología , Estudios Transversales , Diagnóstico Diferencial , Formas de Dosificación , Fatiga/sangre , Fatiga/etiología , Ferritinas/sangre , Humanos , Hierro/administración & dosificación , Hierro/sangre , Compuestos de Hierro/administración & dosificación , Compuestos de Hierro/efectos adversos , Valores de Referencia , Síndrome de las Piernas Inquietas/sangre , Síndrome de las Piernas Inquietas/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA